BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 10678049)

  • 1. [Expression of the bcl-2 and bax oncoprotein in TCC and its clinical significances].
    Yang B; Gu F; Wang X
    Zhonghua Wai Ke Za Zhi; 1997 Oct; 35(10):602-4. PubMed ID: 10678049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of bcl-2 and bcl-X in bladder cancer.
    Kirsh EJ; Baunoch DA; Stadler WM
    J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of apoptosis, cell proliferation and bcl-2 expression in transitional cell carcinoma of the bladder: association with tumor progression.
    King ED; Matteson J; Jacobs SC; Kyprianou N
    J Urol; 1996 Jan; 155(1):316-20. PubMed ID: 7490878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder].
    Leng J; Zhang Y; Yao X; Wen K
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):40-3. PubMed ID: 11831985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential role of bcl-2 and bax mRNA and protein expression in chronic hepatitis type B and C: a clinicopathologic study.
    Tsamandas AC; Thomopoulos K; Zolota V; Kourelis T; Karatzas T; Ravazoula P; Tepetes K; Petsas T; Karavias D; Karatza C; Bonikos DS; Gogos C
    Mod Pathol; 2003 Dec; 16(12):1273-88. PubMed ID: 14681329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of Bcl-2 and Bax tumor cell expression in patients with non muscle-invasive bladder cancer receiving bacillus Calmette-Guerin immunotherapy.
    Ajili F; Kaabi B; Darouiche A; Tounsi H; Kourda N; Chebil M; Manai M; Boubaker S
    Ultrastruct Pathol; 2012 Feb; 36(1):31-9. PubMed ID: 22292735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of frameshift mutations in the bax gene in renal cell cancer (RCC) and transitional cell cancer (TCC).
    Bilim VN; Kawasaki T; Takahashi K; Tomita Y
    Anticancer Res; 1998; 18(3A):1655-9. PubMed ID: 9673385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The expression and significance of bcl-2 and bax in each phase of the cell cycle in laryngeal carcinoma].
    Chen WL; Guo XF; Quan CS; Luan XY
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):157-61. PubMed ID: 15283295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of hypoxia inducible factor-1alpha and glucose transporter protein 1 in renal and bladder cancers and the clinical significance thereof].
    Zhou JT; Cai ZM; Li NC; Na YQ
    Zhonghua Yi Xue Za Zhi; 2006 Jul; 86(28):1970-4. PubMed ID: 17064593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of Bcl-2 and Bax protein in endometriosis].
    Huang FY; Lin QH; Fang XL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Apr; 28(2):102-6. PubMed ID: 12934347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of bcl-2, bax and p53 protein in the basal cell carcinoma].
    Yan L; Chen M; Yu G
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(2):179-80. PubMed ID: 11938785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis and the expression of Bcl-2 and Bax in patients with endometrioid, clear cell, and serous carcinomas of the uterine endometrium.
    Kokawa K; Shikone T; Otani T; Nishiyama R; Ishii Y; Yagi S; Yamoto M
    Gynecol Oncol; 2001 May; 81(2):178-83. PubMed ID: 11330946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Expression of apoptosis and Bcl-2, Bax in hemangioma and vascular malformations].
    Wang B; Zhuang FL; Zhang PF; Zhang S; Lin H
    Zhonghua Zheng Xing Wai Ke Za Zhi; 2003 Sep; 19(5):347-9. PubMed ID: 15179873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
    J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can expression of apoptosis genes, bcl-2 and bax, predict survival and responsiveness to chemotherapy in node-negative breast cancer patients?
    Kymionis GD; Dimitrakakis CE; Konstadoulakis MM; Arzimanoglou I; Leandros E; Chalkiadakis G; Keramopoulos A; Michalas S
    J Surg Res; 2001 Aug; 99(2):161-8. PubMed ID: 11469882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Germ cell apoptosis and expression of Bcl-2 and Bax following testicular torsion/detorsion in rats].
    Liu ZM; Zheng XM; Li SW; Yang ZW; Hu LQ
    Zhonghua Nan Ke Xue; 2003 Feb; 9(1):40-2, 68. PubMed ID: 12680330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Apoptosis of renal cell carcinoma and apoptotic related genes bcl-2 and bax].
    Yang B; Gu F; Li H; Kong X; Yu L
    Zhonghua Wai Ke Za Zhi; 1998 Jun; 36(6):373-5. PubMed ID: 11825416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of survivin does not predict survival in patients with transitional cell carcinoma of the upper urinary tract.
    Nakanishi K; Tominaga S; Hiroi S; Kawai T; Aida S; Kasamatsu H; Aurues T; Hayashi T; Ikeda T
    Virchows Arch; 2002 Dec; 441(6):559-63. PubMed ID: 12461612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the apoptosis accelerator Bax in rheumatoid arthritis synovium.
    Hilbers I; Hansen T; Petrow PK; Gaumann A; Bräuer R; Salzmann G; Gay RE; Kosmehl H; Kirkpatrick CJ; Gay S; Kriegsmann J
    Rheumatol Int; 2003 Mar; 23(2):75-81. PubMed ID: 12634940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.